New combo inhaler aims to stop asthma attacks faster

NCT ID NCT05555290

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 3 trial tested whether a combination inhaler containing albuterol and budesonide (PT027) works better than albuterol alone (PT007) for treating sudden asthma attacks. 190 adults with asthma who only used rescue inhalers as needed took part. Researchers measured lung function after triggering airway obstruction with mannitol. The goal was to see if the combo inhaler improves breathing more quickly or effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
albuterol and budesonide combination inhaler
What this could lead to
If it works, this could offer a more effective rescue inhaler for asthma attacks by combining a bronchodilator with an anti-inflammatory.
What could go wrong
This is a completed Phase 3 trial, but results may not show a meaningful advantage over standard albuterol. The study used mannitol to trigger attacks, which may not reflect real-world asthma triggers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Columbia, Maryland, 21046, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.